This compound is primarily utilized in the field of medicinal chemistry, particularly in the development of novel therapeutic agents. It serves as a key intermediate in the synthesis of small molecule drugs targeting specific proteins involved in disease pathways. Its structure is often incorporated into proteolysis-targeting chimeras (PROTACs), which are designed to degrade disease-causing proteins selectively. Additionally, it has shown potential in the research of anti-inflammatory and anticancer agents due to its ability to modulate biological pathways effectively. Its fluorinated isoindoline moiety enhances its binding affinity and stability, making it a valuable component in drug discovery and development.